Low concentrations of curcumin induce growth arrest and apoptosis in skin keratinocytes only in combination with UVA or visible light

被引:75
作者
Dujic, Jadranka
Kippenberger, Stefan
Hoffmann, Stephanie
Ramirez-Bosca, Ana
Miquel, Jaime
Diaz-Alperi, Jocluin
Bereiter-Hahn, Juergen
Kaufmann, Roland
Bernd, August
机构
[1] Goethe Univ Frankfurt, Sch Med, Dept Dermatol & Venerol, D-60590 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Dept Zool, Kinemat Cell Res Grp, D-60590 Frankfurt, Germany
[3] AIE, ASAC Pharmaceut Int, Alicante, Spain
[4] Univ Alicante, Sch Med, Dept Therapeut & Pharmacol, E-03080 Alicante, Spain
关键词
D O I
10.1038/sj.jid.5700801
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
It is well known that curcumin, a dietary pigment from the plant Curcuma longa, inhibits cell proliferation and induces apoptosis in different cell lines at concentrations ranging from 10 to 150 mu(M) (3.7-55 mu g/ml). In this study, we show that curcumin at low concentrations (0.2-1 mu g/ml) also has an anti proliferative effect when applied in combination with UVA or visible light. We demonstrate that such a treatment induces apoptosis in human skin keratinocytes represented by the increase of fragmented cell nuclei, release of cytochrome c from mitochondria, activation of caspases-9 and -8, and inhibition of NF-kappa B activity. Furthermore, inhibition of extracellular regulated kinases 1/2 and protein kinase B was found to ensure the proapoptotic effect. Additionally, the EGFR, an upstream regulator of both kinases, was inhibited indicating that apoptosis is induced by blocking survival- and proliferation -associated signal cascades at the receptor level. In summary, these findings suggest a new therapeutic concept for the treatment of hyperproliferative diseases by combining topical curcumin with UVA or visible light. In particular, the latter avoids the use of carcinogenic irradiation that is part of regular phototherapy.
引用
收藏
页码:1992 / 2000
页数:9
相关论文
共 43 条
[1]
Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling [J].
Aggarwal, S ;
Takada, Y ;
Singh, S ;
Myers, JN ;
Aggarwal, BB .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (05) :679-692
[2]
PHORBOL-ESTER-INDUCED ACTIVATION OF THE NF-KAPPA-B TRANSCRIPTION FACTOR INVOLVES DISSOCIATION OF AN APPARENTLY CYTOPLASMIC NF-KAPPA-B/INHIBITOR COMPLEX [J].
BAEUERLE, PA ;
LENARDO, M ;
PIERCE, JW ;
BALTIMORE, D .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1988, 53 :789-798
[3]
Control of apoptosis by Rel/NF-κB transcription factors [J].
Barkett, M ;
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6910-6924
[4]
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis [J].
Bharti, AC ;
Donato, N ;
Singh, S ;
Aggarwal, BB .
BLOOD, 2003, 101 (03) :1053-1062
[5]
P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells [J].
Bielak-Zmijewska, A ;
Piwocka, K ;
Magalska, A ;
Sikora, E .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (02) :179-185
[6]
NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[7]
BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809
[8]
Bush RL, 2001, J ENDOVASC THER, V8, P53, DOI 10.1583/1545-1550(2001)008<0053:ESPACE>2.0.CO
[9]
2
[10]
Inhibition of telomerase activity and induction of apoptosis by curcurnin in K-562 cells [J].
Chakraborty, S ;
Ghosh, U ;
Bhattacharyya, NP ;
Bhattacharya, RK ;
Roy, M .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 596 (1-2) :81-90